Yves Husemann
Overview
Explore the profile of Yves Husemann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
1385
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kranz L, Diken M, Haas H, Kreiter S, Loquai C, Reuter K, et al.
Nature
. 2016 Jun;
534(7607):396-401.
PMID: 27281205
Lymphoid organs, in which antigen presenting cells (APCs) are in close proximity to T cells, are the ideal microenvironment for efficient priming and amplification of T-cell responses. However, the systemic...
2.
Kreiter S, Diken M, Selmi A, Diekmann J, Attig S, Husemann Y, et al.
Cancer Res
. 2011 Aug;
71(19):6132-42.
PMID: 21816907
Intranodal immunization with antigen-encoding naked RNA may offer a simple and safe approach to induce antitumor immunity. RNA taken up by nodal dendritic cells (DC) coactivates toll-like receptor (TLR) signaling...
3.
Conrad C, Husemann Y, Niess H, von Luettichau I, Huss R, Bauer C, et al.
Ann Surg
. 2010 Dec;
253(3):566-71.
PMID: 21169810
Objective: To specifically target tumor angiogenesis by linking transgene expression of engineered mesenchymal stem cells to angiopoietin-1-induced differentiation. Background: Mesenchymal stem cells (MSCs) have been used to deliver therapeutic genes...
4.
Husemann Y, Klein C
Transgenic Res
. 2008 Nov;
18(1):1-5.
PMID: 19002597
Human metastasis has been modeled mostly by xenotransplantation of cell lines in immunodeficient mice. Since this approach frequently uses cell lines derived from metastases, it ignores the significant role of...
5.
Husemann Y, Geigl J, Schubert F, Musiani P, Meyer M, Burghart E, et al.
Cancer Cell
. 2008 Jan;
13(1):58-68.
PMID: 18167340
It is widely accepted that metastasis is a late event in cancer progression. Here, however, we show that tumor cells can disseminate systemically from earliest epithelial alterations in HER-2 and...